S

Sandu Pharmaceuticals Limited

SANDUPHQ
Market snapshot · 2026-08-11 12:06 UTC

39.46

₹-0.34 (-0.85%)

MARKET CAP

₹38.12 Cr

STOCK P/E

21.6x

52W HIGH

₹51.00

52W LOW

₹30.00

BOOK VALUE

₹40.25

EPS

₹1.83

ROE

4.12%

SECTOR

Consumer Staples

DEBT/EQUITY

0.96

VOLUME

1,463

P/B RATIO

0.98x

PEG RATIO

Sector

Consumer Staples

Themes

FMCG - Personal Products
D
Dividend
₹48.85₹44.74₹40.64₹36.53₹32.42VolumeDAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Trading 25.4% below historical median. Valuation is declining — currently in the strongly undervalued zone (z-score: -1.22). Confidence: 80%.

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/E
Strongly Undervalued

5Y Average

29.53

Current

21.56

Overvalued

32.08

Undervalued

23.96

EV/EBITDA
Strongly Undervalued

5Y Average

16.77

Current

12.25

Overvalued

19.24

Undervalued

14.75

P/S
Strongly Undervalued

5Y Average

0.75

Current

0.55

Overvalued

0.86

Undervalued

0.63

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹17 CrMar 2026

Latest net profit

₹0.00 CrMar 2026

Latest EPS

₹0.04Mar 2026

Net margin

2.4%Mar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.0%2.0%4.0%6.0%8.0%0.00 Cr5.00 Cr10 Cr15 Cr20 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr5.00 Cr10 Cr15 Cr20 Cr₹0₹0₹1₹1₹1
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOtheradjustmentsOperatingprofitOther incomeInterestOtheradjustmentsProfitbefore taxTax & otherNet Profit0.00 Cr5.00 Cr10 Cr15 Cr20 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Debt free
Mar 2025Sep 2025Mar 20260.00 Cr15 Cr30 Cr45 Cr60 Cr
  • Free cash flow
  • Cash & equivalents

Results

Sales

₹17 Cr

+19.8%

Net Profit

₹0 Cr

-86.7%

EBITDA

₹1 Cr

+80.8%

EPS

₹0.04

-88.2%
MetricMar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales1417181917
Expenses1416171816
Operating Profit00110
OPM %2.13%2.08%3.93%4.66%2.42%
Other Income00000
Interest00000
Depreciation00000
Profit before tax00111
Tax %4.67%34.07%26.63%-14.05%94.58%
Net Profit00110
EPS in Rs0.340.230.541.010.04

All values in ₹ Crores unless otherwise stated. Source: Company filings.

Loading shareholding pattern...